(Q36013613)

11 August 2017

1 reference

title

Anaplastic giant cell thyroid carcinoma (English)

1 reference

11 August 2017

G Wallin

1

1 reference

11 August 2017

G Lundell

series ordinal

2

1 reference

11 August 2017

J Tennvall

series ordinal

3

1 reference

11 August 2017

publication date

1 January 2004

1 reference

Scandinavian Journal of Surgery

11 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 August 2017

volume

93

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

272-277

1 reference

Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Excisional surgery for cancer cure: therapy at a cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Biologic basis for altered fractionation schemes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Anaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Combination therapy for anaplastic giant cell thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Spindle and giant cell carcinoma of the thyroid: a different therapeutic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Cellular effects of combined adriamycin and x-irradiation in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Lack of a point mutation of human DNA topoisomerase II in multidrug-resistant anaplastic thyroid carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Combretastatin A4 phosphate has primary antineoplastic activity against human anaplastic thyroid carcinoma cell lines and xenograft tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749690409300404

10.1177/145749690409300404

21 January 2018

Identifiers

DOI

0 references

1 reference